GB0226723D0 - Antibodies for in vitro use - Google Patents

Antibodies for in vitro use

Info

Publication number
GB0226723D0
GB0226723D0 GB0226723A GB0226723A GB0226723D0 GB 0226723 D0 GB0226723 D0 GB 0226723D0 GB 0226723 A GB0226723 A GB 0226723A GB 0226723 A GB0226723 A GB 0226723A GB 0226723 D0 GB0226723 D0 GB 0226723D0
Authority
GB
United Kingdom
Prior art keywords
antibodies
vitro use
vitro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0226723A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Priority to GB0226723A priority Critical patent/GB0226723D0/en
Publication of GB0226723D0 publication Critical patent/GB0226723D0/en
Priority to AU2003219277A priority patent/AU2003219277A1/en
Priority to PCT/GB2003/001077 priority patent/WO2003077945A1/en
Priority to JP2004570301A priority patent/JP2006521088A/en
Priority to PCT/GB2003/004953 priority patent/WO2004046188A2/en
Priority to AU2003282247A priority patent/AU2003282247A1/en
Priority to EP03773865A priority patent/EP1565495A2/en
Priority to PCT/GB2003/004944 priority patent/WO2004046187A2/en
Priority to CA002506128A priority patent/CA2506128A1/en
Priority to AU2003282241A priority patent/AU2003282241A1/en
Priority to US11/127,903 priority patent/US20050288492A1/en
Ceased legal-status Critical Current

Links

GB0226723A 2002-03-14 2002-11-15 Antibodies for in vitro use Ceased GB0226723D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GB0226723A GB0226723D0 (en) 2002-11-15 2002-11-15 Antibodies for in vitro use
AU2003219277A AU2003219277A1 (en) 2002-03-14 2003-03-14 Intracellular antibodies
PCT/GB2003/001077 WO2003077945A1 (en) 2002-03-14 2003-03-14 Intracellular antibodies
AU2003282241A AU2003282241A1 (en) 2002-11-15 2003-11-14 Antibodies for in vitro use
PCT/GB2003/004953 WO2004046188A2 (en) 2002-11-15 2003-11-14 Anti-activated ras antibodies
JP2004570301A JP2006521088A (en) 2002-11-15 2003-11-14 Anti-activated RAS antibody
AU2003282247A AU2003282247A1 (en) 2002-11-15 2003-11-14 Anti-activated ras antibodies
EP03773865A EP1565495A2 (en) 2002-11-15 2003-11-14 Anti-activated ras antibodies
PCT/GB2003/004944 WO2004046187A2 (en) 2002-11-15 2003-11-14 Antibodies for in vitro use
CA002506128A CA2506128A1 (en) 2002-11-15 2003-11-14 Anti-activated ras antibodies
US11/127,903 US20050288492A1 (en) 2002-11-15 2005-05-12 Anti-activated RAS antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0226723A GB0226723D0 (en) 2002-11-15 2002-11-15 Antibodies for in vitro use

Publications (1)

Publication Number Publication Date
GB0226723D0 true GB0226723D0 (en) 2002-12-24

Family

ID=9947929

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0226723A Ceased GB0226723D0 (en) 2002-03-14 2002-11-15 Antibodies for in vitro use

Country Status (3)

Country Link
AU (1) AU2003282241A1 (en)
GB (1) GB0226723D0 (en)
WO (1) WO2004046187A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2911514A1 (en) 2013-05-06 2014-11-13 Scholar Rock, Inc. Compositions and methods for growth factor modulation
PL3218005T3 (en) 2014-11-12 2023-05-02 Seagen Inc. Glycan-interacting compounds and methods of use
US9879087B2 (en) 2014-11-12 2018-01-30 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
IL302822A (en) 2015-11-12 2023-07-01 Seagen Inc Glycan-interacting compounds and methods of use
WO2018094143A1 (en) 2016-11-17 2018-05-24 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
BR112019018043A2 (en) 2017-03-03 2020-04-07 Seattle Genetics Inc cancer treatment method, and, antibody-drug conjugate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2344886B (en) * 1999-03-10 2000-11-01 Medical Res Council Selection of intracellular immunoglobulins
AU2002355477B2 (en) * 2001-08-03 2008-09-25 Medical Research Council Method of identifying a consensus sequence for intracellular antibodies
WO2003077945A1 (en) * 2002-03-14 2003-09-25 Medical Research Council Intracellular antibodies

Also Published As

Publication number Publication date
WO2004046187A2 (en) 2004-06-03
AU2003282241A8 (en) 2004-06-15
AU2003282241A1 (en) 2004-06-15
WO2004046187A3 (en) 2004-08-12

Similar Documents

Publication Publication Date Title
EP1494693A4 (en) Cripto-specific antibodies
IL241315A (en) Method for enhancing the in vitro shelf-life of purified -glucocerebrosidase
IL165804A0 (en) In vitro fertilisation
PL375405A1 (en) Antibodies
IL225633A0 (en) Anti-alpha-v-beta - 6 antibodies and uses thereof
PT1599504E (en) Modified antibody
IL175710A0 (en) Anti-mpl antibody
EP1551447A4 (en) Anti-addl antibodies and uses thereof
IL175608A0 (en) Antibodies
AU2003217912A8 (en) Antibody optimization
EP1572131A4 (en) Antibody therapy
EP1535930A4 (en) Antibody specific to central tetra-protein
AU2003239197A8 (en) Novel stable anti-cd22 antibodies
EP1699485A4 (en) Anti-hydroxylase antibodies and uses thereof
IL172510A0 (en) Antibodies and uses thereof
IL172511A0 (en) Specific human antibodies
EP1497649A4 (en) Antibodies specific for mucin polypeptide
EP1589033A4 (en) Antibody and use thereof
IL166063A0 (en) Antibodies and uses thereof
GB0226723D0 (en) Antibodies for in vitro use
AU2002953238A0 (en) In vitro immunization
GB0306618D0 (en) Antibody
GB0226878D0 (en) Antibodies
EP1627888A4 (en) Antibody and use thereof
HK1209139A1 (en) Modified antibody

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)